The detection of bacterial infections in leukemia patients using procalcitionin levels

References

• Vento S, Cainelli F. Infections in patients with cancer undergoing chemotherapy: aetiology, prevention, and treatment. Lancet Oncol. 2003;4:595–604.
   PubMed Web of Science ®Google Scholar
• Kolonen A, Sinisalo M, Huttunen R, et al. Bloodstream infections in acute myeloid leukemia patients treated according to the Finnish Leukemia Group AML-2003 protocol – a prospective nationwide study. Infect Dis (Lond). 2017;49:799–808.
   PubMed Web of Science ®Google Scholar
• Jiang L, Feng B, Gao D, et al. Plasma concentrations of copeptin, C-reactive protein and procalcitonin are positively correlated with APACHE II scores in patients with sepsis. J Int Med Res. 2015;43:188–195.
   PubMed Web of Science ®Google Scholar
• Carnino L, Betteto S, Loiacono M, et al. Procalcitonin as a predictive marker of infections in chemoinduced neutropenia. J Cancer Res Clin Oncol. 2010;136:611–615.
   PubMed Web of Science ®Google Scholar
• Mancini N, Carletti S, Ghidoli N, et al. The era of molecular and other non-culture-based methods in diagnosis of sepsis. Clin Microbiol Rev. 2010;23:235–251.
   PubMed Web of Science ®Google Scholar
• Nellis ME, Pon S, Giambrone AE, et al. The diagnostic accuracy of serum procalcitonin for bacteremia in critically ill children. Infect Dis Clin Pract (Baltim Md). 2016;24:343–347.
   PubMed Web of Science ®Google Scholar
• de Jong E, van Oers JA, Beishuizen A, et al. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. Lancet Infect Dis. 2016;16:819–827.
   PubMed Web of Science ®Google Scholar
• Alba GA, Truong QA, Gaggin HK, et al. Diagnostic and prognostic utility of procalcitonin in patients presenting to the Emergency Department with Dyspnea. Am J Med. 2016;129:96.e7–104.e7.
   Web of Science ®Google Scholar
• Lautz AJ, Dziorny AC, Denson AR, et al. Value of procalcitonin measurement for early evidence of severe bacterial infections in the pediatric intensive care unit. J Pediatr. 2016;179:74.e72–81.e72.
   Web of Science ®Google Scholar
• Becker KL, Nylen ES, White JC, et al. Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab. 2004;89:1512–1525.
   PubMed Web of Science ®Google Scholar
• Carrol ED, Thomson AP, Hart CA. Procalcitonin as a marker of sepsis. Int J Antimicrob Agents. 2002;20:1–9.
   PubMed Web of Science ®Google Scholar
• Nijsten MW, Olinga P, The TH, et al. Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med. 2000;28:458–461.
   PubMed Web of Science ®Google Scholar
• Zant R, Stocker C, Schlapbach LJ, et al. Procalcitonin in the early course post pediatric cardiac surgery. Pediatr Crit Care Med. 2016;17:624–629.
   PubMedGoogle Scholar
• Vyles D, Gnagi F, Bulloch B, et al. Procalcitonin as a marker of bacteremia in patients with fever and acute lymphoblastic leukemia. Pediatr Emerg Care. 2016;32:590–593.
   PubMed Web of Science ®Google Scholar
• Dandona P, Nix D, Wilson MF, et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab. 1994;79:1605–1608.
   PubMed Web of Science ®Google Scholar
• Gilbert DN. Procalcitonin as a biomarker in respiratory tract infection. Clin Infect Dis. 2011;52:S346–S350.
   PubMed Web of Science ®Google Scholar
• Hong J, Woo HS, Ahn HK, et al. Pre-treatment blood inflammatory markers as predictors of systemic infection during induction chemotherapy: results of an exploratory study in patients with acute myeloid leukemia. Support Care Cancer. 2016;24:187–194.
   PubMed Web of Science ®Google Scholar
• Nuutila J. The novel applications of the quantitative analysis of neutrophil cell surface FcgammaRI (CD64) to the diagnosis of infectious and inflammatory diseases. Curr Opin Infect Dis. 2010;23:268–274.
   PubMed Web of Science ®Google Scholar
• Roques M, Chretien ML, Favennec C, et al. Evolution of procalcitonin, C-reactive protein and fibrinogen levels in neutropenic leukaemia patients with invasive pulmonary aspergillosis or mucormycosis. Mycoses 2016;59:383–390.
   PubMed Web of Science ®Google Scholar
• Rodriguez AH, Aviles-Jurado FX, Diaz E, et al. Procalcitonin (PCT) levels for ruling-out bacterial coinfection in ICU patients with influenza: a CHAID decision-tree analysis. J Infect. 2016;72:143–151.
   PubMed Web of Science ®Google Scholar
• Buyukberber N, Buyukberber S, Sevinc A, et al. Cytokine concentrations are not predictive of bacteremia in febrile neutropenic patients. Med Oncol. 2009;26:55–61.
   PubMed Web of Science ®Google Scholar
• Jeong S, Park Y, Cho Y, et al. Diagnostic utilities of procalcitonin and C-reactive protein for the prediction of bacteremia determined by blood culture. Clin Chim Acta. 2012;413:1731–1736.
   PubMed Web of Science ®Google Scholar
• Mandell IM, Aghamohammadi S, Deakers T, et al. Procalcitonin to detect suspected bacterial infections in the PICU. Pediatr Crit Care Med. 2016;17:e4–12.
   PubMed Web of Science ®Google Scholar
• Jacobs DM, Holsen M, Chen S, et al. Procalcitonin to detect bacterial infections in critically ill pediatric patients. Clin Pediatr (Phila). 2017;56:821–827.
   PubMed Web of Science ®Google Scholar
• Thomas-Ruddel DO, Poidinger B, Kott M, et al. Influence of pathogen and focus of infection on procalcitonin values in sepsis patients with bacteremia or candidemia. Crit Care. 2018;22:128
   PubMed Web of Science ®Google Scholar
• Cabral L, Afreixo V, Meireles R, et al. Evaluation of procalcitonin accuracy for the distinction between Gram-negative and Gram-positive bacterial sepsis in burn patients. J Burn Care Res. 2019;40:112–119.
   PubMed Web of Science ®Google Scholar